Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a maintenance update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-05-17T09:24:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now explicitly lists 'Multiple myeloma' as the condition. It adds a 'related topics' section with MedlinePlus Genetics as a linked resource.
    Difference
    0.2%
    Check dated 2026-05-03T00:57:05.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a site update rather than any modification to the ClinicalTrials.gov study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:25:29.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Removed mentions of 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.5.0'.
    Difference
    0.2%
    Check dated 2026-04-18T13:26:47.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added related topics for 'Multiple myeloma' and 'MedlinePlus Genetics', and updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T17:24:40.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision label changed from v3.4.2 to v3.4.3. This appears to be a minor backend or display update with no observable changes to the study details or page content.
    Difference
    0.1%
    Check dated 2026-03-06T17:41:44.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.